Edition:
United States

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.31USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
86,929
52-wk High
$6.08
52-wk Low
$1.20

Chart for

About

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulatio... (more)

Overall

Beta: 0.33
Market Cap(Mil.): $3.07
Shares Outstanding(Mil.): 2.35
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 34.52 17.27
EPS (TTM): -- -- --
ROI: -- 14.12 35.43
ROE: -- 16.75 17.10

BRIEF-Neurometrix Inc Says Net Loss Was About $2.9 Mln In Q4 2017 Compared To $2.8 Mln In Q4 2016

* NEUROMETRIX REPORTS Q4 AND FULL YEAR 2017 FINANCIAL RESULTS

Jan 25 2018

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

Jan 17 2018

BRIEF-Neurometrix Reports Preliminary 2017 Financial Highlights

* NEUROMETRIX INC - PRELIMINARY GAAP REVENUE FOR Q4 OF 2017 IS ESTIMATED AT APPROXIMATELY $4.9 MILLION IN COMPARISON WITH $3.7 MILLION IN Q4 2016 Source text for Eikon: Further company coverage:

Jan 08 2018

BRIEF-NeuroMetrix CFO reports purchase of 2,500 shares of co's common stock on Oct 23 at $1.77 per share

* NeuroMetrix Inc CFO Thomas​ ‍Higgins reports purchase of 2,500 shares of co's common stock on Oct 23 at $1.77 per share - sec filing Source text (http://bit.ly/2gBQZj2) Further company coverage:

Oct 23 2017

Competitors

  Price Chg
Natus Medical Inc (BABY.OQ) $30.85 --

Earnings vs. Estimates